4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052780
SVP, Diagnostics, clonoSEQ sold 10,000 shares at $50.00 ($500,000)
- SVP, Diagnostics, clonoSEQ acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-09-29 | Option exercise | +10,000 | $1.98 | $19,800 | 10,000 | D: show line 1 in the form |
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-09-29 | Sale | −10,000 | $50.00 | $500,000 | 0 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $50.00 · $500,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-09-29 | Option exercise · Stock Option (Right to Buy) | −10,000 | 55,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…